230 related articles for article (PubMed ID: 22189845)
1. Operative management for recurrent and metastatic adrenocortical carcinoma.
Datrice NM; Langan RC; Ripley RT; Kemp CD; Steinberg SM; Wood BJ; Libutti SK; Fojo T; Schrump DS; Avital I
J Surg Oncol; 2012 Jun; 105(7):709-13. PubMed ID: 22189845
[TBL] [Abstract][Full Text] [Related]
2. Outcome after resection of Adrenocortical Carcinoma liver metastases: a retrospective study.
Baur J; Büntemeyer TO; Megerle F; Deutschbein T; Spitzweg C; Quinkler M; Nawroth P; Kroiss M; Germer CT; Fassnacht M; Steger U;
BMC Cancer; 2017 Aug; 17(1):522. PubMed ID: 28778197
[TBL] [Abstract][Full Text] [Related]
3. Surgical resection of synchronously metastatic adrenocortical cancer.
Dy BM; Strajina V; Cayo AK; Richards ML; Farley DR; Grant CS; Harmsen WS; Evans DB; Grubbs EG; Bible KC; Young WF; Perrier ND; Que FG; Nagorney DM; Lee JE; Thompson GB
Ann Surg Oncol; 2015 Jan; 22(1):146-51. PubMed ID: 25092161
[TBL] [Abstract][Full Text] [Related]
4. Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma.
Tran TB; Maithel SK; Pawlik TM; Wang TS; Hatzaras I; Phay JE; Fields RC; Weber SM; Sicklick JK; Yopp AC; Duh QY; Solorzano CC; Votanopoulos KI; Poultsides GA
J Am Coll Surg; 2016 Dec; 223(6):794-803. PubMed ID: 27618748
[TBL] [Abstract][Full Text] [Related]
5. Resection of adrenocortical carcinoma liver metastasis: is it justified?
Gaujoux S; Al-Ahmadie H; Allen PJ; Gonen M; Shia J; D'Angelica M; Dematteo R; Fong Y; Blumgart L; Jarnagin WR
Ann Surg Oncol; 2012 Aug; 19(8):2643-51. PubMed ID: 22526905
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma.
Schulick RD; Brennan MF
Ann Surg Oncol; 1999 Dec; 6(8):719-26. PubMed ID: 10622498
[TBL] [Abstract][Full Text] [Related]
7. Operative Management of Recurrent and Metastatic Adrenocortical Carcinoma: A Systematic Review.
Lo WM; Kariya CM; Hernandez JM
Am Surg; 2019 Jan; 85(1):23-28. PubMed ID: 30760340
[TBL] [Abstract][Full Text] [Related]
8. Operative intervention for recurrent adrenocortical cancer.
Dy BM; Wise KB; Richards ML; Young WF; Grant CS; Bible KC; Rosedahl J; Harmsen WS; Farley DR; Thompson GB
Surgery; 2013 Dec; 154(6):1292-9; discussion 1299. PubMed ID: 24238048
[TBL] [Abstract][Full Text] [Related]
9. Surgery for recurrent adrenocortical carcinoma: A multicenter retrospective study.
Simon G; Pattou F; Mirallié E; Lifante JC; Nominé C; Arnault V; de Calan L; Caillard C; Carnaille B; Brunaud L; Laplace N; Caiazzo R; Blanchard C
Surgery; 2017 Jan; 161(1):249-256. PubMed ID: 27855966
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary resection for metastatic adrenocortical carcinoma: the National Cancer Institute experience.
Kemp CD; Ripley RT; Mathur A; Steinberg SM; Nguyen DM; Fojo T; Schrump DS
Ann Thorac Surg; 2011 Oct; 92(4):1195-200. PubMed ID: 21958764
[TBL] [Abstract][Full Text] [Related]
11. Operative intervention for recurrence of adrenocortical carcinoma: A single-center experience.
Zhang F; Liu Z; Liang J; Tang Y; Liu S; Zhou C; Zhang F; Wu K; Lu Y; Wang X
Surgery; 2021 May; 169(5):1131-1138. PubMed ID: 33279225
[TBL] [Abstract][Full Text] [Related]
12. Adrenocortical carcinoma surgery-surgical extent and approach.
Vanbrugghe C; Lowery AJ; Golffier C; Taieb D; Sebag F
Langenbecks Arch Surg; 2016 Nov; 401(7):991-997. PubMed ID: 27412357
[TBL] [Abstract][Full Text] [Related]
13. Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center.
Ayala-Ramirez M; Jasim S; Feng L; Ejaz S; Deniz F; Busaidy N; Waguespack SG; Naing A; Sircar K; Wood CG; Pagliaro L; Jimenez C; Vassilopoulou-Sellin R; Habra MA
Eur J Endocrinol; 2013 Dec; 169(6):891-899. PubMed ID: 24086089
[TBL] [Abstract][Full Text] [Related]
14. Clinical Score Predicting Overall Survival After Surgery for Synchronous Metastatic Adrenocortical Carcinoma: A Surveillance, Epidemiology, and End Result-Based Study.
Wu K; Liu Z; Li X; Lu Y
Am Surg; 2021 May; 87(5):805-811. PubMed ID: 33228399
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival after adrenalectomy for stage I/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of laparoscopic versus open approach.
Donatini G; Caiazzo R; Do Cao C; Aubert S; Zerrweck C; El-Kathib Z; Gauthier T; Leteurtre E; Wemeau JL; Vantyghem MC; Carnaille B; Pattou F
Ann Surg Oncol; 2014 Jan; 21(1):284-91. PubMed ID: 24046101
[TBL] [Abstract][Full Text] [Related]
16. Adrenocortical carcinoma extending into the inferior vena cava: presentation of a 15-patient series and review of the literature.
Chiche L; Dousset B; Kieffer E; Chapuis Y
Surgery; 2006 Jan; 139(1):15-27. PubMed ID: 16364713
[TBL] [Abstract][Full Text] [Related]
17. Features of synchronous versus metachronous metastasectomy in adrenal cortical carcinoma: Analysis from the US adrenocortical carcinoma database.
Prendergast KM; Smith PM; Tran TB; Postlewait LM; Maithel SK; Prescott JD; Pawlik TM; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay JE; Shirley LA; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Votanopoulos KI; Levine EA; Poultsides GA; Solórzano CC; Kiernan CM
Surgery; 2020 Feb; 167(2):352-357. PubMed ID: 31272813
[TBL] [Abstract][Full Text] [Related]
18. Surgery is associated with improved survival for adrenocortical cancer, even in metastatic disease.
Livhits M; Li N; Yeh MW; Harari A
Surgery; 2014 Dec; 156(6):1531-40; discussion 1540-1. PubMed ID: 25456949
[TBL] [Abstract][Full Text] [Related]
19. Disease-free interval and tumor functional status can be used to select patients for resection/ablation of liver metastases from adrenocortical carcinoma: insights from a multi-institutional study.
Ayabe RI; Narayan RR; Ruff SM; Wach MM; Lo W; Nierop PMH; Steinberg SM; Ripley RT; Davis JL; Koerkamp BG; D'Angelica MI; Kingham TP; Jarnagin WR; Hernandez JM
HPB (Oxford); 2020 Jan; 22(1):169-175. PubMed ID: 31447392
[TBL] [Abstract][Full Text] [Related]
20. Patterns of Lymph Node Recurrence in Adrenocortical Carcinoma: Possible Implications for Primary Surgical Treatment.
Reibetanz J; Rinn B; Kunz AS; Flemming S; Ronchi CL; Kroiss M; Deutschbein T; Pulzer A; Hahner S; Kocot A; Germer CT; Fassnacht M; Jurowich C
Ann Surg Oncol; 2019 Feb; 26(2):531-538. PubMed ID: 30443830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
